E. coli Vaccine

About Immunethep

Immunethep is a private, clinical-stage biotech based in Porto, Portugal, leveraging a proprietary immunomodulatory platform to develop novel anti-infective therapies. The company's pipeline includes both vaccine and monoclonal antibody candidates targeting serious bacterial infections, with programs supported by non-dilutive funding from entities like CARB-X and PACE. With a seasoned leadership team and backing from prominent Portuguese venture capital firms, Immunethep is positioning itself as a key player in the global fight against antimicrobial resistance.

Therapeutic Areas